Overview

Hyzaar Asia HEAALTH (0954A-950)

Status:
Completed

Trial end date:
2007-04-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to estimate the percentage of patients who reach blood pressure goal after 8 weeks of treatment with losartan/HCTZ combination.

Phase:

Phase 3

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Hydrochlorothiazide
Losartan